End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.64 USD | +2.17% | -6.00% | +20.77% |
05-23 | Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing | MT |
05-10 | Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating | MT |
Chart calendar Zura Bio Limited
Upcoming events on Zura Bio Limited
Past events on Zura Bio Limited
2024-05-09 06:00 | Q1 2024 Earnings Release |
2024-03-28 06:00 | Q4 2023 Earnings Release |
2024-03-17 | BioEurope Spring Conference |
2024-03-13 | Eighth Systemic Sclerosis World Congress |
2024-03-11 13:20 | Leerink Partners Global Biopharma Conference |
2024-02-23 09:00 | Piper Sandler TSLP Biology Day |
2024-02-13 08:00 | Oppenheimer Healthcare Life Sciences Conference |
2024-02-07 15:00 | Guggenheim Healthcare Talks Biotechnology Conference |
2024-02-04 | Oppenheimer Winter CEO and Investor Summit |
2024-01-11 15:00 | JPMorgan Healthcare Conference |
2024-01-07 16:00 | Dermatology Summit |
2023-11-30 | World Allergy Congress - Abstract No : WAC23-0180 |
2023-11-30 | World Allergy Congress - Abstract No : WAC23-0179 |
2023-11-27 | Evercore ISI HealthCONx Conference |
2023-11-13 06:30 | Q3 2023 Earnings Release |
2023-11-05 | Guggenheim Securities Inflammation & Immunology Conference |
2023-09-19 11:00 | Stifel Immunology and Inflammation Summit |
2023-08-14 07:00 | Q2 2023 Earnings Release |
Annual results
Fiscal Period | December | 2023 | 2024 |
---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -62,6 -62,3 -0.56% | -39,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -60,6 -62,7 3.39% | -36,7 |
Net income Million USD | Released Forecast Spread | -60,4 -73,5 17.9% | -36,7 |
EPS USD | Released Forecast Spread | -2,09 -2,62 20.35% | -0,52 |
Announcement Date | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million USD | Released Forecast Spread | -33,9 -8,20 -313.27% | -10,2 -10,1 -0.47% | -10,8 -10,5 -3.29% | -8,38 -11,2 25.27% | -8,95 | -10,1 | -12,3 | -13,0 | -14,2 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -34,0 -8,65 -293.42% | -8,27 -10,4 20.63% | -8,47 -10,6 20.05% | -7,75 -11,4 31.8% | -8,34 | -9,18 | -11,4 | -11,8 | -13,0 | |
Net income Million USD | Released Forecast Spread | -9,59 | -44,9 -8,65 -419.17% | -8,27 -10,4 20.63% | -8,47 -10,6 20.05% | -7,75 -11,4 31.8% | -8,34 | -9,18 | -11,4 | -11,8 | -13,0 |
EPS USD | Released Forecast Spread | -1,31 -0,25 -431.07% | -0,18 -0,24 23.4% | -0,23 | -0,02 -0,24 91.53% | -0,14 | -0,15 | -0,17 | -0,17 | -0,18 | |
Announcement Date | 12/05/23 | 14/08/23 | 13/11/23 | 28/03/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Zura Bio Limited
2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 16:01 | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZURA Stock
- Calendar Zura Bio Limited